1,100
Participants
Start Date
December 31, 2011
Primary Completion Date
August 31, 2017
Study Completion Date
August 31, 2017
6 months DAPT
Dual antiplatelet therapy will be stopped at randomisation to the 6 months DAPT group. Patients will be treated from 6 months onwards only with ASA.
12 months DAPT
Dual antiplatelet therapy will be continued till 12 months after enrollment in the study
Hôpital Cantonal Fribourg, Fribourg
Małopolskie Centrum Sercowo-Naczyniowe PAKS, Chrzanów
Polsko-Amerykańskie Kliniki Serca, Dąbrowa Górnicza
Amerykańskie Kliniki Serca, Bielsko-Biala
VU medisch Centrum, Amsterdam
Amphia ziekenhuis, Breda
Medisch Spectrum Twente, Enschede
Atrium MC Parkstad, Heerlen
Erasmus MC, Rotterdam
Isala Clinics, Zwolle
Oslo University Hospital, Oslo
Polsko_Amerykanskei Kliniki Serca, Kędzierzyn-Koźle
University Hospital in Krakow, Krakow
Polsko_Amerykanskei Kliniki Serca, Nysa
Maasstadhospital, Rotterdam
Haga Hospital, The Hague
Collaborators (1)
Medtronic
INDUSTRY
Maasstad Hospital
OTHER